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To d©icrmme lira actw¢ site residue, human milk bllc.(alt stimulated lipasc (BSSL) was In. l ied with pH]d)isopropyl i'luoropho(phaic (DFP) Partial 
sequence analysis of cyanollen bromide frailmenl,~ (a total of 146 residues rfom 6 peptide'.) re~,calcd 114~, sequence Idchttly with a putallv¢ rat ly~o. 
pho,tphollpaN Sequence analysLs of a pl'l]DFP-I=~bcllcd pcptid¢ indicated that Ihc actwc ,qle ,=ermc ~ts contained in the ~qttcnce Gly.Glu.Ser Ale. 
Gly, In addtl=on to ,qn,dartty wah tel ly=tophosphohpu~, thi~ sequence shewed homololly with reilmn=t or human hut~'rylchohn¢~l,crasc ,and electric 
ray acctylch©ltncsierase (6t~)deni=ty). It == concluded that these proteins ~tre mcml~r= ofn new =upcrllen¢ family 
Human milk htle.~all stimulated hpa(c, Ly,topho~phohpa~=. Acttvo x)lc Acetylchohnc~tcram 
1. INTRODUCTION 
The major lipase activity in human milk is stimulated 
by bile-salts (bile.salt stimulated hpase; BSSL), This 
lipase is activated by bile salts containing a 7-hydroxyl 
group [1,2] and the enzyme contributes sigmflcantly to 
the utilization of milk lipids in the newborn [3]. 
The BSSL enzyme is very non-specific, hydrolysmg a 
wide range of triglycerides as well as cholesterol and 
aryl and alkyl esters [2,4]. It represents 1°70 of human 
milk protein and has been purified using several pro- 
cedures [5,6]. The reported molecular masses of the two 
preparations of BSSL are 125 000 and 90000. This dif- 
ference ts likely to be due to variauons in the mobility 
of this glycoprotem in different gel electrophoresis 
systems. Blackberg and Hernell [6] showed that treat- 
ment with DFP resulted in inhibition of activity and m. 
corporation of radiolabelled reagent into the protein. 
The properties of BSSL are very simdar to a bile salt- 
stimulated hpase, carboxyl-ester hydrolase (CEH) 
which is present in human pancreatic secretions [7,8]. 
The amino acid content was shown to be similar to rat 
cholesterol esterase and bovine lysophospholipase and 
these authors suggested that the three activities may 
belong to the same protein. Immunological and kinetic 
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¢.omparisons mdicated that the bile-salt stimulated 
hpases In human milk and pancreatic juice were very 
similar [91. 
The NH=-terminal 22 residues of the milk enzyme 
have been reported [5]. Recently the NHz-termmal 30 
residues of human pancreatic carboxylesterase and milk 
bile-salt stimulated lipase were found to be identical 
and to show a high degree of homology with rat and 
dog pancreatic arboxylesterases [ 10]. 
In the present study we have obtained part)el amino 
acid sequence data for the human milk enzyme and 
found a high degree of sequence similarity with a 
putative rat lysophosphohpase, d duced from a cloned 
eDNA corresponding to the largest mRNA species 
isolated from adult rat pancreas [11], In addition, the 
sequence containing a serme residue reactive w~th DFP 
was determined and found to be homologous with ac- 
tive site sequences of cholmesterases. 
2. MATERIALS AND METHODS 
2 1 Preparation of BSSL 
The enzyme was purff=ed from fresh human mdk using the pro- 
cedure described [6] The enzyme was dlalysed extensively, freeze. 
dried and stored at 4°C prior to u~e 
2,2 Reaction of BSSL wlth IJHJDFP 
An ahquot (100 /~10 10O ,uC0 of radloact,vely labelled DFP 
[I,3-~H]DFP (NEN, Dupont, 3 Cl,'mmol) was combined with 10.al of 
unlabelled DFP it0 86/~M m propan 2-ol) and 78 ,ul ('70 9/zCl/100 
nmol) added to the BSSL enz:'me ( - 2 mg m l ml of 5 mM sodmm 
barbltone/0 I M NaCI, pH 7 4 ). The enzyme was incubated (final 
concentration 0 I mM DFP) for 30 mm at 37°C and apphed to a 
column (l 6x22  cm) of Sephadex G-25 equilibrated with 0 I M 
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NfI~HCO~, I'r~wiiol|S (0 1~[ nil} were ¢ulhl¢ied lind tdiquots token for 
r.dlo~¢lt~,~ d,~tcrmlnathm A I~t#l ef I0 IIq~¢l ~f I~|I]I}[Fp r~dio#¢, 
[ i~,l l~ ' w~s Incorporated into protein. Thh t:orresponded to an in. 
¢orporahon of I~,~ nmol DFP,'2S nmol I~S~lk (O,61 m~/m¢tlJl 
a|,mmlnll a molecular mas,; of 65 0OO and E i,~ *' I :l,6 for the BSSL ca. 
#yme itOl, An ~tllquot of the labelled prepar~tion w~s ~nalysed by 
SO~.poiyacryMmldc I1¢1 electrophcwe~h on a I {]~ ~rylamtde II~l [I : l ,  
Protein w~t~ d,~tcetcd by Coom,~sle blue stainln[t ¢md rttdio;tcli~,e 
bands, detected b~ I fluorollraphy o~inll ~odlum ~liwl.~te ll3) The 
r.dina¢ll~,lty Of [ HlDFP.contalninll fr~ctloa~ w~, determined by 
~.intlllallvn count[nit (LKB We[line Betarnc} The efflOency of coun. 
tins w~s $,?,¢t=. 
2 3 Preparolton of CA'Br,¢ I¢~H'O~I¢ ~fpcpt/d¢# of I~tl/DFP.labellcd 
BSSL 
Appro~lmmely I~ nmol or I'Hll)FP,l~belled BSSL v~s d l~hed 
in 100~l of 70% formic a~ld c~ntamin$ l0 m~ CNBr ~nd incubated 
for 6 h at room telnpcrnture and then o~,ernt~ht at 4"C follos~ed by 
ffccm dryln$ ~tfter dlhmon with wdter, The sampl~ u, as redlssolvctl in 
600 #1 or 6 M tiaanine.}lCI in 0 I% aqueous trilquoroncetlc acid and 
injecled onto n Vydac C4 (0,46x2~ cm) column equilibrated with 
90% sob, ent A {0 I% aqueous trifluoroace[Ic acid)and 10% solvent 
B (800"o a~.etonitrllcl0 I% trifluoroacctlc acid) The column was 
timed ~tth a hnear iirndient of 10% to 700'0 solvent B over tl0 ram, 
,it a I ml/min now rate, Pep[ides were delected by absorban~e at ~14 
nm Atiquois of fractlOltS s~crc titk~n for sc;attllatlon countlnl Pep, 
tides reco,,crcd from this r~olunln were further purified usln$ sllnllar 
~.oad=tmns on a Vydac Phenyl column (O 46x25 cm) In some cases, 
additional purification v, as carried out by microbore HPLC usinli an 
Aquapore RP]00 CR column (0 2x22 cm), a 140A solvem dehsery 
s~,.stcm ,and IO00S diode array detector (Apphed Btosystems) 
2 4 Protein .Y¢qi~ett¢e ¢malrx#A 
Seqpen~.e ,tnalysts was performed using a gas pllase sequencer 
(model 470A) ¢qtappcd with an on.hne phenylthlohydantom amino 
acid aaalyser (120A) v, lth f.hem=~.als and the program (03RP1 H) sup 
phed by the manufacturer (Apphed Btosystems), Protein sequence 
data was used to search the NBR[" database (release 28 O) usm8 the 
University of W[sconslll software [14] 
3. RESULTS 
Prchminaty kinetic studies showed that treatment 
wlth a 2-10-rold molar excess of DFP  resulted m com- 
plete mhibitlon of human milk hpase actwny. Incuba- 
tlon with [~H]DFP  resulted in the labelhng of the en- 
zyme to a specific aclivlty of 0.43 #C1/nmol  (0,61 mol 
DFP/mol  o f  enzyme). Analysis by SDS-polyacrylamide 
gel electrophorests and f luorography showed that the 
radmactwsty was incorporated rote a single component  
running as a broad band,  Mr 120000 (Fig, 1) which cor- 
responded to the major  protein detected by Coomasste 
blue staining In the preparat ion.  
3 1. Sequence slrmlarlty of  BSSL and rat lysophos. 
pholipase 
Cleavage of  the protein at methtonine residues w~th 
CNBr  resulted m the conversmn of all o f  the [3H]DFP- 
labelled material to low molecular weight material as in- 
dicated by SDS-polyacrylam~de gel electrophorcs~s 
(data not shown), The CNBr  fragments were separated 
by reverse phase HPLC (Fig. 2). A number  o f  the CNBr  
pep[ides f rom pools denoted C, D, and E were further 









Fill, I, &nalysis or BSSL by SDS.polyacrylamide =el electrophores[s 
A sample or [~H]DrP.labcllcd BSSL was run on a 10% poly 
nt.rylamide iel m the presence o1" SDS under reductnB t.ondltions, (I) 
Smmm8 with Coomasste blue, (2) detection cf radioactively labelled 
material By fluoroaraphy. 
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Fig, 2, $eparahon of CNBr-cleavase peptldes from [~H]DFP.labelled 
BSSL by reverse phase HPLC The CNBr-dlgested material was 
dissolved in 600/~l of 6 M guamdme.HCl/0 107o trlfluoroacetlc acld 
and injected onto a Vydac C4 column (0 46 x 25 cm) equilibrated with 
90% solvent A (0 I% aqueous tnfluoroacetlc a Ld) and 100/0 solvent 
B (80070 acetonltnle/0 I% trlfluoroaceuc acld) The column was 
eluted with a linear gradient of lO~0 to 70°70 solvent B over 80 rain at 
l mVmln now rate Peptldes in pools C-13, D20 and E-I were further 
purihed and ~ubjected tosequence analysis (Ft8 3A) Pools E and F 
contained all of the [3H]DFP-labelled material which was recovered 
from the column (62% of radtoacw.lty mjccted onto the column) 
The majority of this ~as recovered m pool F (7607o). A pepude CB, 
F7.9A was purified and subjected to sequence analysts (Table l, 
Fl$ 3B) 
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F)Ii. 3 NH~.tcrmlnal sequences of CNBr.¢Ica~a$¢ pcptltle~ I'rom [~HIDFP.hibdled BS'~t and comparison with ~¢l]lll¢l'lls OI' rat I)'~ophospholipaw 
and chohnesternse~, (A) Ahitnment of NHa.terminal scquenq;c~ of CNBr peptides D20.:l, E-I, D:0.5, C-•3 and i'7.9Al ~iJl~ rat ly~ophosphohp,tse, 
lysoPL [I 31. The reco~.e='y of phenyh hiohydnnlo~n a~r, no a~.kh al cycle I of Edman dellradal~on corresponded to 3~. i l l ,  90 and 6 pmol rot I'~ephdes 
D20-3, E.I, D20.~, and C.I1, r¢,=p¢~;l=v¢ly, Tire a',erag¢ repet)t=..e y=eld~ for those ¢.orresponded to 91 6, 92 5, 95 0 and 9"/40'0, r¢~,pcet~,cl~¢ (B) 
Alignmertt o1' the NH=.termmal sequ¢~t¢:c of the [~HIDFP labelled Oept,de, CI| 1"?-9AI w=th regions of lysoPL, human bt, tyrylcl~011,~es~crase 
hBuChF- [I 81 I]lld marbled ray aeetyh.hol,ne,~teras¢, rayAChE [191 Identical rc~due~ are mdv.ated ( - ) " Ind~¢at¢~ I)~e po~lt~on ¢orrespo*tdlnl~l to
tl~e rel=ase of' rndtoacttvlly, 
automated sequence analysts, A search of the NBRF 
prote,n sequence database with each of these sequences 
revealed sequence similarity with a putative rat lyso- 
phosphohpase (Fig. 3A). The observed sequence idenu- 
ty for these alignments corresponded to 82 out of 99 
residues (83°70 identity), No sequence similarity was 
identified with other lipases. 
3.2. Charactertzatton o f  [)HlDFP.labelletl matertal 
from the CNBr dtgest of  BSSL 
All of the [~H]DFP.labelled materml following 
HPLC was recovered in pools E and F (Ftg. 2). The 
overall recovery from the column was 62° ,  76°70 of 
which was recovered m pool F. This fraction contained 
a number of peptides which were very difficult to 
separate. This necessitated repeated reverse phase 
HPLC, using a variety of columns and conditions and 
resulted in high adsorptive losses of the labelled 
material. Fractions containing peptides of highest 
specific activity were pooled from each HPLC run. A 
fraction, designated F7-gA was obtained which con- 
taming 9,8°'/0 of the inmal pool F radioactivity. An ali- 
quot of thin fraction (containing 99000 cpm eqmvalent 
to 120 pmol [3H]DFF-containing material) was sub- 
jected to automated sequence analysis. This gave two 
sequences in approximately equal amounts. However, 
one of the sequences, designated CB F7-9A1 was 
equwalent to residues 190-217 of rat lysophospholipase 
(93070 identity). The NHz-terminal 19 residues of the 
other pept~de CB F7-gA2 was slmdar to residues 
275-293 of rat lysophospholipase (Table I, Fig. 3At. 
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The sequencing ¢ffic:ency of the two peptldes differed 
and residues 12-28 of pepudc F7-9AI could be tden- 
tlfted without reference to the rat sequence The se- 
quence of peptLde CB F7-9A1 corresponded to Ala- 
lie - Ale -Trp - Val - Lys- Arg -Ash- lie- Ala- Ala- Phe - Gly- 
Gly-As p-Pro-Asn-Asn-lle-Thr.Leu.Phe-Gly-Glu.(Ser). 
Ala-Gly-Gly and pepttde CB F7-9A2, Ala-GIn-(Cys)- 
Leu-Lys-VaI-Thr-Asp.Pro-Val-Ala- Leu-Thr-Leu-Ala- 
Tyr-Lys-Leu-Pro. The release of radioactivity at each 
cycle of Edman degradation is also shown m Table I. It 
can be seen that radtoactivtty was released at cycle 
number 25 indicating that the sequence Gly-Glu-Ser- 
Ala-Gly m pepude CB F7-9AI comams a serme which 
~s reactive w:th DFP. In a separate xperiment the re- 
mainder of the material from pool F7-9A was reduced 
and alkylated and two peptldes F7-9AI and F7-92 were 
separated by HPLC Automated sequence analysis 
verified the NH2-termmai sequences of each of these 
peptides and indicated that the two peptides are linked 
by a disulphide bond (data not shown). 
3.3. Homology of  human mdk B$SL and rat pan- 
crea,c hpase acttve stte sequences wtth cho- 
Ir ~esterase 
The N-terminal 28 residues of peptide CB F7-9A1 
containing the DFP reacuve site had a high degree of se- 
quence identity with residues 190-217 of rat lysophos- 
pholipase. Both of these sequences showed sequence 
homology with active site regions of human butyryl- 
chohnesterase and electric ray acetylcholinesterase 
(Ftg. 3B). 
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table I 
IIS~L 
(-'~,¢1~ Amino .¢ld I+llIDl~ P rlDoPk rlytoPl-. 
(Ymld pmoll (¢pm) (1~O=31"/1 (l'/~l.,lOll 
AL~(I IZ) i1~0 Ale Ale 
2 tier48) Gin(31) ?~ lie Gly 
;! Alat21 } $;t AI~ C~t 
4 Trptl6) ke~t26) 6S rrp Lcu 
S VnI(,ll } [-,ystZJ) I | Val kyt 
6 Ly'~(24) Val(21~} U -~ L)~ II~ 
? ArctiC} Thr(10) $4 Arll Thr 
II Asn(i4l Asp(21] 62 A~n A~p 
9 Ile[211) Protlg) 66 lie Pro 
10 AI~(3]) Vnl(R} 2 IR Aht Ar~ 
I I Ala[~4) 107 AI= AI~ 
I 2 Phet30} Leu( I El) 106 Pile t =tl 
13 Gly(241 Thr(~) 9,1 Gly rhr 
14 Gly(21) Leu(3} 102 GI)' Leu 
I ~ Asp(19) AlaS9) 116 A~p AI~ 
16 Pro(20) Tyr( I O) 136 Pro T:,'r 
17 A~,n(~l) Ly,,(~) I I~.~ Asp Art= 
114 Asnt I I~) L~ut4} I I~4 Ash Leu 
19 lie(16) Pro(3) I "/? lie Pro 
20 Thr{6) 200 Thr Lcu 
21 LeuC9) 195 lie Lys 
22 Phe(13) 200 phe 5¢r 
23 C31)(8) 191 GI) Gin 
24 Ohl($) 196 Gh~ Glu 
2~ (Ser)" 1420 Ser T~r 
26 Ale(S) 804 Ale Pro 
27 GI)(4) 390 GIy lie 
28 Gly(4) 220 Gly 
"l'l~e [:tH]DrP peptlde subjected to sequence analysts ~.ontamed 99000 
cpm Th=s is equivalent to 120 peal based on the sp¢c=ftc act=vet:,' (043 
/+Ci/nmol) follo~mg re,u.uon of II~e BSSL en/yme with [~H]DFP 
The ~ampl¢ was not reduced and alkylated so C)s at posHmn 3 ~ould 
not t~ave been detected. (Ser)* Tht,. rcmdue was alerted from the 
release of rad~oactwtty correspondm8 to tlus cycle The ~equences of 
resaduen 190-217 and 27S-301 of rat lysophosphohpasc (rlysoPL) as 
reported [11] are shmvn lot t.ompar=son 
4. DISCUSSION 
Human milk BSSL has many properties m common 
w~th a carboxyl-ester hydrolase (CEH) found in the 
pancreatic jmce from a number of species. It appears 
that the carboxylesterase ts responmble for actwmes 
known as cholesterol esterase, non.specific lipase and 
lysophosphohpase [15]. In the present study, the rela- 
tionship of BSSL to the pancreauc enzymes has been 
clarified by parttal aroma acid sequence analysis. A 
high degree of  sequence slmilar2ty was observed be- 
tween BSSL and a putauve rat lysophosphohpase [11] 
The sequence of peptide CB D20-3 corresponded to 
the NH2-termmal sequence of  BSSL (data not shown, 
[5]). Recently, the NH2-termmal sequences of  pan- 
creat~c CEHs were reported and compared to BSSL 
[10]. The NH2-termmal 30 residues of human CEH and 
BSSL were idenucal and a high degree of homology was 
seen between these sequences and those of dog, rat and 
p~g CEH.  We note that the reported NH2-termmal se- 
quence of rat CEH [10) corresponds exacdy with 
residues 21-36 of rat lyosophospholip~e, indlcalln8 
that this protein contains a 20 residue lead=r sequence 
[i11, 
The ~. livity of BSSL is very sensitive to the acdon of  
DFP  [6,16]. incorporation of  [~HJDFP resulted in the 
labellinll of a ! 10-120 kDa band which is in allrccmen( 
with the relative molecular masses reported for BSSL in 
human pancreatic CEH iS,6,10]. The human enzyme 
appears to be extensively lllycosylated compared with 
rat CEH [10], Automated Edman dellradadon of a 
[IHJDFP.labelled peptlde revealed sequences car- 
responding to two peptidcs (CB FT-9AI and CB 
F'/.9A2) which appear to be linked by a disulphide 
bond, The two sequences were aligned with sequences 
commenc ing  at remdues 190 and 27S of the rat se- 
quence. [t is s~nlflcant that in the rat sequence both se. 
quences are preceded by a methtomne residue and cys. 
seine residues are found at positions 266 and 277, In ad- 
dition, Cys residues corresponding to these positions 
have been shown to form a disulphtde bridge in 
Torpedo acetylchohnesterase [17], The NH=-termin=l 
sequences of CB FT-9AI and CB FT-9A2 together with 
data obtained from the four other CNBr-peptides 
(Ftg. 3A) provide a total of 146 residues. This Is 
eqmvalent to approx,mately 25°;'o of the BSSL se. 
quence, assuming the same number of residues as 
reported for rat lysophospholipase [11]. It is tmportant 
to note that the six CNBr pepttdes revealed sequence 
similarity with segments found throughout the rat 
lysophospholipase quence [11]. Furthermore, all of 
the BSSL CNBr peptldcs tart at positrons preceded by 
Met m the rat sequence, except CBD20-5 where the 
preceding residue was lie. With the exceptton of pept=de 
CB F7-9AI (discussed below) search of the NBRF data 
base revealed no obvious homologies other than with 
rat lysophosphohpase It is hkely, therefore, that BSSL 
represents the species counterpart of rat iysophospho- 
hpase CEI l  and that 2t represents a pancreatic protein 
which is also secreted by' the lactating mammary glands 
in humans. 
Sequence analyms of pepttde CB F7-9AI resulted m 
the release of radioacuvlty at posmon 25, md~catmg 
that th~s posmon contatns the serme wh=ch reacts wtth 
DFP. Th~s residue Is contamed wi the  a sequence -Gly- 
Xaa.Ser-Xaa-Gly- which is a consensus equence found 
in the active s~te of pancreatic hpase, serme proteases 
and chohnesterases Search nf the NBRF database with 
the NI--lz-termmal sequence of  CB, FT-gA 1 revealed ad- 
dltmnal homology (16/28 ~denttttes) w~th human 
butyrylchohnesterase and marbled ray acetylcholin- 
esterase [18,19]. This homology is conmstent w~th the 
esterase actwlty and DFP sensitivity of BSSL. It was of 
interest o compare the enure rat lysophosphohpase e-
quence w~th human butyrylchohnesterase [18]. The two 
protems were found to be 32°70 ~denucal using the pro- 
gram GAP (data not shown). 
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In conclusion, il appears that BSSL and human pan. 
¢re~tic CEH =tre likely to be =dendcal, repre=en(in¢ ~h¢ 
~pecie~ coumerp~rz~ of r~t lysophozpholipn~e (CEH).  
BSSI. i~ a member o f  a supergenc family includins 
cholinestcrases, 
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